Renaissance Technologies - SUCAMPO PHARMACEUTICALS INC ownership

SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 181 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SUCAMPO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$35,139,000
+128.1%
1,957,600
+49.9%
0.04%
+116.7%
Q3 2017$15,407,000
+81.0%
1,305,700
+61.1%
0.02%
+63.6%
Q2 2017$8,511,000
-30.4%
810,600
-27.1%
0.01%
-35.3%
Q1 2017$12,225,000
-38.2%
1,111,400
-23.9%
0.02%
-45.2%
Q4 2016$19,780,000
+18.8%
1,459,800
+7.9%
0.03%
+6.9%
Q3 2016$16,655,000
+37.1%
1,353,000
+22.1%
0.03%
+26.1%
Q2 2016$12,151,000
+34.6%
1,107,700
+34.2%
0.02%
+35.3%
Q1 2016$9,025,000
-5.9%
825,700
+48.8%
0.02%
-19.0%
Q4 2015$9,592,000
+9.2%
554,800
+25.5%
0.02%0.0%
Q3 2015$8,785,000
+60.0%
442,100
+32.3%
0.02%
+61.5%
Q2 2015$5,489,000
+57.7%
334,100
+49.3%
0.01%
+85.7%
Q1 2015$3,481,000
+314.4%
223,714
+280.5%
0.01%
+250.0%
Q4 2014$840,000
+148.5%
58,800
+63.3%
0.00%
+100.0%
Q4 2013$338,000
-57.6%
36,000
-71.8%
0.00%
-50.0%
Q3 2013$797,000
-48.4%
127,800
-45.6%
0.00%
-50.0%
Q2 2013$1,546,000235,0000.00%
Other shareholders
SUCAMPO PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 51,630$336,0000.32%
Granahan Investment Management 1,389,775$9,034,0000.28%
Visium Asset Management, LP 1,806,200$11,740,0000.17%
MENTA CAPITAL LLC 96,507$627,0000.10%
OBERWEIS ASSET MANAGEMENT INC/ 51,700$336,0000.09%
CADENCE CAPITAL MANAGEMENT LLC 152,632$992,0000.05%
Spark Investment Management LLC 41,200$267,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 27,600$179,0000.02%
GLOBEFLEX CAPITAL L P 29,800$194,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 130,500$848,0000.02%
View complete list of SUCAMPO PHARMACEUTICALS INC shareholders